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We report an ongoing measles outbreak in Manaus, 
Amazonas state, Brazil. As at 3 November 2018, 1,631 
cases were confirmed corresponding to an incidence 
of 75.3 per 100,000 inhabitants; all five sanitary dis-
tricts presented confirmed cases. Reintroduction of 
measles virus in Manaus is likely related to the cur-
rent outbreak in Venezuela and due to recent decline 
in measles vaccine coverage. Given the current sce-
nario, prevention and control measures should target 
individuals aged 15–29 years.
In February 2018, a measles outbreak was reported in 
the state of Roraima, Brazil and was found to be asso-
ciated with the ongoing measles outbreak in Venezuela 
[1]. As at 10 December 2018, 349 cases have been 
confirmed [2]. Between 2001 and 2017, the Amazonas 
state did not report any confirmed measles cases 
[3]. Here, we report the ongoing measles outbreak in 
Manaus capital of the Amazonas state in Brazil. The 
north of Amazonas state borders Venezuela. Manaus 
has 2,145,444 inhabitants.
Case definition, laboratory testing and 
investigations
In 1969, the Ministry of Health (MoH) in Brazil estab-
lished that all suspected measles cases seeking 
health services must be notified to the local authori-
ties; cases must also be registered in the National 
System of Notifiable Diseases (Sinan) [4]. In addition, 
an ad hoc system known as ‘TRACK’ was made avail-
able in Manaus during the epidemiological week (EW) 
19 (starting on 12 May 2018) to track register all data 
collected in the health services and through interviews 
in the present outbreak. In this study, we included all 
cases registered in TRACK until 3 November 2018 who 
lived in Manaus and met the suspected case definition 
(Box) [5-7].
 In Brazil, all samples processed by the public health 
laboratory network are registered in the Laboratory 
Environment Management System (GAL); test results 
obtained in the ongoing outbreak available in GAL 
were also registered in TRACK to support case classi-
fication. The epidemiological and laboratory investiga-
tions, as well as contact tracing, were conducted by 
the Secretariat of Health of the municipality of Manaus, 
together with the Amazonas State Health Secretariat 
and the Brazilian MoH. All samples were sent to the 
National Reference Laboratory at the Oswaldo Cruz 
Foundation (Fiocruz) in Rio de Janeiro. Those who met 
the clinical criteria and presented laboratory confirma-
tion were considered as ‘confirmed’.
Outbreak onset
The first laboratory confirmed case of the ongoing 
outbreak was a woman in her early 20s living in the 
northern district of Manaus. She had rash onset on 21 
February 2018 and presented with fever, cough, coryza 
and conjunctivitis. She was identified during the inves-
tigation of her one-year old child’s case who had rash 
onset on 1 March and presented the same symptoms 
as the mother. Laboratory confirmation of measles was 
obtained on 23 March 2018.
The D8 genotype measles virus was identified in a 
urine sample from the infant, which was identical to 
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the one that is circulating in Venezuela; genotyping 
also showed that it was a wild-type measles virus. 
The mother reported having had contact with three 
Venezuelan migrants in January 2018, whom were 
interviewed by the surveillance team; one of them pre-
sented with malaise, diarrhoea, high fever and redness 
in the body soon after arriving in Manaus, but denied 
having presented with measles rash. None of the 
migrants had a history of vaccination against measles. 
The migrants did not match the case definition for noti-
fication and were identified retrospectively, 40 days 
after their symptom onset, therefore, laboratory tests 
were not carried out as too much time had elapsed. 
The infant did not have contact with the migrants dur-
ing the incubation period; the only contacts were the 
mother and father, and the latter had been vaccinated 
against measles. Therefore, the probable source of 
infection of the infant was the mother.
Although the current available information suggest a 
link between the outbreaks in Venezuela and Manaus, 
further molecular epidemiological studies are needed 
to help understanding the reintroduction of measles in 
the municipality.
Epidemiological situation
From 6 February–3 November 2018, 8,070 suspected 
cases were notified; of these, 5,971 (74.0%) were 
still under investigation. Among the cases with com-
plete investigation, 1,631 (77.7%) were confirmed 
and 468 (22.3%) were discarded; the median interval 
between the date of notification and the date of the 
final classification of the case was 37 days (range 
0–140 days). All the confirmed cases were Brazilians. 
The incidence of measles among confirmed cases was 
75.3 per 100,000 inhabitants; the incidence was higher 
among infants (1,003.9/100,000 inhabitants) and chil-
dren aged 1–4 years (175.3/100,000 inhabitants). Up 
to 3 November, the northern district accounted for the 
largest number of cases (2,753 cases) (Table 1).
The epidemic curve shows a gradual increase in the 
number of cases with symptom onset from 6 May, 
reaching a peak of 763 cases in EW 29 (15–21 July), 
then decreasing gradually (Figure 1). The median 
reporting delay was 1 day (range 0–155 days), consid-
ering the difference between the notification and rash 
onset dates; therefore, the decrease in the number of 
notifications from the EW 30 onwards does not seem 
to be explained by the reporting delay. All five districts 
presented confirmed cases, which indicates the circu-
lation of the virus throughout the municipality (Figure 
2). 
Of 7,602 notified cases, the majority (55.5%) were 
male; among women, 86 of 3,385 (2.5%) were preg-
nant. The age group with the highest number of cases 
(26.6%) was the 20–29-year-olds, followed by those 
aged 15–19 years (23.3%). Together, these two age 
groups comprised ca 50% of all notifications (Table 1). 
Up to week EW 22, most cases were in the age group of 
6 months–4 years, from the EW 23 onwards, however, 
an increase of cases aged 15–29 years was observed 
(Figure 3A).
Box
Definition of cases and other categories followed-up during the measles outbreak, Manaus, Amazonas, Brazil, 2018 
Suspected case:
• Any person in whom a health professional suspects measles infection; or
• Any person with fever and maculopapular rash (i.e. non-vesicular) and cough, coryza (i.e. runny nose) or conjunctivitis (i.e. red eyes); 
or
• Any person with a history of travel to sites with measles virus circulation in the last 30 days, or who has had contact in the past 30 
days with someone who has travelled to sites with viral circulation.
Confirmed case:
Laboratory: A case that meets the clinical case definition and has laboratory-confirmation of measles virus infection:
• A positive serologic test for measles immunoglobulin M antibody; or
• Isolation of measles virus from a clinical specimen; or
• Detection of measles-virus specific nucleic acid from a clinical specimen using polymerase chain reaction; or
• IgG seroconversion or a significant rise in measles immunoglobulin G antibody using any evaluated and validated method.
Epidemiologically: A case that meets the clinical case definition and has contact with a laboratory-confirmed measles case whose rash 
onset was within the preceding 21 days, or a case that lives in the same district or adjacent districts where a measles outbreak has 
been laboratory- confirmed and transmission is plausible.
Discarded case:
A suspected case, which, upon adequate investigation that includes a blood specimen collected in the appropriate time frame, lacks 
serologic evidence of a measles virus infection.
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Table 1








n % Incidence per 100,000 inhabitants n % Incidence per 100,000 inhabitants
Sanitary district
East 2,454 32.3 460.1 525 32.2 98.4
North 2,753 36.2 461.5 506 31.0 84.8
West 1,011 13.3 211.3 290 17.8 60.6
South 1,325 17.4 253.4 270 16.6 51.6
Rural 59 0.8 418.2 40 2.5 283.5
Sex
Female 3,385 44.5 355.2 755 46.3 79.2
Male 4,217 55.5 463.9 876 53.7 96.4
Age group
< 6 months 549 7.2 2828.6b 203 12.5 1003.9b
6–11.9  months 578 7.6 2828.6b 197 12.1 1003.9b
1–4 years 746 9.8 489.9 267 16.4 175.3
5–9 years 314 4.1 160.1 100 6.1 51.0
10–14 years 355 4.7 166.3 116 7.1 54.4
15–19 years 1,770 23.3 853.1 225 13.8 108.4
20–29 years 2,021 26.6 467.3 332 20.4 76.8
30–39 years 830 10.9 229.0 101 6.2 27.9
40–49 years 319 4.2 113.8 61 3.7 21.8
50 + years 120 1.6 42.8 29 1.8 10.3
Pregnancy
No 3,299 97.5 NA 744 98.5 NA
Yes 86 2.5 NA 11 1.5 NA
Admitted to hospital
No 6,289 88.4 NA 1,164 71.9 NA
Yes 823 11.6 NA 455 28.1 NA
Vaccination status
No 5,411 75.0 NA 1,288 82.9 NA
Yes 1,801 25.0 NA 265 17.1 NA
Signs and symptoms
Cough
No 494 6.5 NA 48 2.9 NA
Yes 7,101 93.5 NA 1582 97.1 NA
Coryza
No 1,773 23.4 NA 235 14.4 NA
Yes 5,809 76.6 NA 1,393 85.6 NA
Conjunctivitis
No 3,188 42 NA 509 31.4 NA
Yes 4,385 58 NA 1,114 68.6 NA
NA: not applicable.
a Includes confirmed cases and those under investigation.
b Incidence based on all infants < 1 year.
Source: Municipal Health Secretariat of Manaus, Amazonas, Brazil. Data extracted on 6 November 2018.
4 www.eurosurveillance.org
Of 7,212 suspected cases, 75.0% had no records of 
vaccination against measles; the percentage was even 
higher among confirmed cases (82.9%) (Table 1). In 
addition, the majority of unvaccinated cases were in 
the age group of 15–29 years (Figure 3B).
Of the 7,602 suspected cases, 823 (11.6%) were hospi-
talised, and the average of the hospitalisation period 
was 4 days (Table 1). As of EW 29, two measles-related 
deaths had been recorded in the municipality of 
Manaus, both in male infants, aged 1 year or younger, 
below the age recommended for the first dose of mea-
sles vaccine, with no comorbidity; the D8 genotype 
was identified in one of the children and the other one 
is still awaiting genotyping.
Brazil vaccination schedule
MCV has been available free of charge in Brazil since 
1967; currently, routine vaccination follows the cal-
endar established by the MoH: one dose of measles, 
mumps, rubella (MMR) vaccine administered at 12 
months of age; one dose of tetravalent vaccine against 
measles, mumps, rubella, varicella (MMRV) at 15 
months; two doses of MMR between 2–29 years of age; 
and one dose of MMR from 30–49 years of age [4,8].
Official data from the MoH indicate that the coverage 
of the first dose of MMR vaccine at 12 months of age 
decreased markedly in Manaus between 2014 and 2017 
(105.7% vs 81.0%); the same pattern was observed for 
the second dose of the vaccine at 15 months of age in 
the same period (95.8% vs 67.0%) [9]. It is noteworthy 
that vaccination coverage in Brazil is obtained through 
an administrative method [10]; a coverage above 100% 
indicates that the number of doses administered in the 
municipality is greater than the number of residents in 
a specific age group and time period.
Control measures
The management of the outbreak have been overseen 
by the MoH and coordinated by the local authorities. 
A situation room was established in Manaus in March 
2018, in order to facilitate the coordination of all strat-
egies for outbreak control and prevention. Since its 
creation, at least two deliberative meetings have been 
held weekly.
To date, several strategies have been adopted to inter-
rupt the outbreak. Suspected cases have been inves-
tigated within 48 hours, searching for the source of 
infection and possible secondary cases. Extensive 
contact tracing for all measles cases has been con-
ducted, verifying the immunisation status of contacts 
and vaccinating susceptible contacts within 72 hours. 
Self-isolation post exposure was also recommended. 
The epidemiological surveillance has been intensified 
through active and retrospective institutional case find-
ing, including the identification of chains of transmis-
sion in the municipality. Initially, the local authorities 
requested immediate isolation of any suspected cases 
Figure 1
Distribution of reported cases of measles according to the epidemiological week of onset of symptoms and investigation 
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Source: Municipal Health Secretariat of Manaus, Amazonas, Brazil. Data extracted on 6 November 2018.
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in reference hospitals. As the number of suspected 
cases increased substantially over time, hospitalisa-
tion became restricted to patients with complications 
given the limited availability of hospital beds.
Routine vaccination has been intensified in Manaus, 
free of charge for individuals aged 12 months–49 years. 
The vaccination campaign was anticipated, targeting 
children aged 12 months–5 years. It was conducted 
from 14–27 April 2018, and reached a coverage of more 
than 95% according to preliminary data provided by the 
MoH [11]. A national campaign was carried out from 6 
August–31 October 2018, targeting individuals aged 12 
months–5 years. Health professionals were hired and 
trained in case management and those with no record 
of vaccination against measles were vaccinated.
The laboratory network was strengthened, ensuring 
that samples were received at the reference laboratory 
within 5 days of collection. A risk communication strat-
egy was implemented and media messages were dis-
seminated, aiming to encourage vaccination when 
appropriate and advising the general population of 
the symptoms suggestive of measles. Epidemiological 
reports were made available weekly at the MoH web-
page [12], as well as technical notes with guidelines on 
flows for epidemiological surveillance, laboratory and 
immunisation.
Discussion
The concentration of cases in children aged 5 years and 
under at the beginning of the outbreak seems to be 
related to a recent decrease in the coverage of measles-
containing vaccines in Manaus, which may have led to 
a marked increase in the number of individuals suscep-
tible to the disease in this age group. Consequently, 
this favoured the reintroduction of the virus in the 
municipality. In this context, the national vaccination 
Figure 2
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Source: Municipal Health Secretariat of Manaus, Amazonas, Brazil. Data extracted on 6 November 2018.
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Figure 3
Proportional distribution of reported cases of measles according to age group, stratified by (A) epidemiological week of 
notification and (B) vaccination statusa, Manaus, Amazonas, Brazil, 6 February–3 November 2018
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B. Reported cases of measles by vaccination status
A. Reported cases of measles by epidemiological week of notification
MMR: measles, mumps, rubella; MMRV: measles, mumps, rubella, varicella.
a Vaccination status is based on the calendar for national routine immunisation established by the Brazilian Ministry of Health, as follows: one dose of MMR 
vaccine administered at 12 months of age; one dose of tetravalent vaccine against MMRV at 15 months; two doses of MMR between 2–29 years of age; and one 
dose of MMR from 30–49 years of age.
Source: Municipal Health Secretariat of Manaus, Amazonas, Brazil. Data extracted on 6 November 2018.
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campaign targeting children aged 6 months–5 years 
seems to have been effective in controlling the spread 
of the virus in this age group. There was a change in 
the age distribution of the cases as the outbreak con-
tinued where more individuals aged 15–29 years were 
affected and the available data indicates that most of 
these individuals had no history of measles vaccina-
tion. As our findings are based on preliminary data, 
these observations should be further investigated in 
the future.
We acknowledge some limitations of our study. First, 
due to the magnitude of the outbreak it was not possi-
ble to carry out laboratory tests for all cases and most 
of the cases are still under investigation. Due to this, 
we opted to present the distributions of both notified 
and confirmed cases. In addition, there is need to con-
sider the epidemiological link for case classification in 
future studies [13].
Second, it was not possible to collect detailed vacci-
nation histories to analyse, as surveillance teams only 
recorded whether an individual had been vaccinated 
with MMR and if so, the date of the last dose.
Our findings highlight the need to increase the aware-
ness among health professionals so that they can bet-
ter recognise and report suspected cases of measles. 
In addition, epidemiological surveillance for timely 
investigation of cases could be strengthened, as well 
as better identification of likely sources of infection 
and secondary cases. Furthermore, given the potential 
number of susceptible individuals in all age groups, it 
is essential to intensify routine vaccination efforts and 
to implement catch-up vaccination, especially for those 
individuals aged 15–29 years. At national level, the risk 
of spread in Brazil is high, taking into account the trans-
missibility of the disease and the performance of the 
routine immunisation programme. At the regional level, 
the potential impact is also considered high given the 
prevention and control capacities in other countries 
in the Region of the Americas [14,15]. Efforts made in 
recent years to eliminate measles in Brazil may be com-
promised if effective measures are not taken to stop 
the transmission of the virus in the northern region of 
the country.
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